Active ingredient: Ciclesonide 80 µg/inhalation, 160 µg/inhalation; metered-dose inhaler. Indication: Maintenance treatment of asthma as prophylactic therapy in patients >12 years of age. Pharmacology ...
Summer temperatures, humidity and allergies are triggers for people diagnosed with asthma. These triggers can range from being a nuisance to being life-threatening. Dr. Jacqueline Squire, a Mayo ...
U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) filing to study the use of Alvesco in COVID-19 Study will evaluate the Safety and Efficacy of Alvesco ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Nonhospitalized patients with COVID-19 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback